Expert perspective regarding the development of selinexor as treatment for relapsed/refractory multiple myeloma and considerations for use in appropriate patients.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
![](https://s2.save4k.ru/pic/Rhr4x-FD_d0/mqdefault.jpg)